Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing
Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism
Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176